Compile Data Set for Download or QSAR
Found 153 of ic50 for UniProtKB: P08581
LigandPNGBDBM517021((R)-1-cyclobutyl-N-(3- fluoro-4-((3-((1- hydroxypr...)copy SMILES
Affinity DataIC50: 0.900nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517033((R)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 0.900nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517014((R)-1- (cyclopropylmethyl)-N- (3-fluoro-4-((3-((1-...)copy SMILES
Affinity DataIC50: 1nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517030((R)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 1.20nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517049((R)-5-cyclopropyl-N-(3- fluoro-4-((3-((1- hydroxyp...)copy SMILES
Affinity DataIC50: 1.5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517002((R)—N-(3-fluoro-4-((3-((1-hydroxypropan-2-yl)amino...)copy SMILES
Affinity DataIC50: 1.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517011((S)-N-(3-fluoro-4-((3- ((3-hydroxy-3- methylbutan-...)copy SMILES
Affinity DataIC50: 1.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516997((R)-N-(3-fluoro-4-((3- ((1-hydroxybutan-2- yl)amin...)copy SMILES
Affinity DataIC50: 1.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517051((R)-5-bromo-N-(3- fluoro-4-((3-((1- hydroxypropan-...)copy SMILES
Affinity DataIC50: 2.20nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517038((R)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 2.30nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517082((S)-1-cyclobutyl-N-(3- fluoro-4-((3-((1- methoxypr...)copy SMILES
Affinity DataIC50: 2.40nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517078((S)-1-ethyl-N-(3-fluoro- 4-((3-((1- methoxypropan-...)copy SMILES
Affinity DataIC50: 2.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517080((S)-1- (cyclopropylmethyl)-N- (3-fluoro-4-((3-((1-...)copy SMILES
Affinity DataIC50: 2.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516979(N-(3-fluoro-4-((3-((1- hydroxy-4-methoxybutan- 2-y...)copy SMILES
Affinity DataIC50: 2.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517044((R)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 2.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516981(N-(4-((3-((4,4-difluoro-1- hydroxybutan-2- yl)amin...)copy SMILES
Affinity DataIC50: 2.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517035((R)-6-cyclopropyl-N-(3- fluoro-4-((3-((1- hydroxyp...)copy SMILES
Affinity DataIC50: 2.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517036((R)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 3nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517084((S)-N-(3-fluoro-4-((3- ((1-methoxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 3nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517109((R)-1-(cyclopropylmethyl)-N-(3-fluoro-4-((3-((1-me...)copy SMILES
Affinity DataIC50: 3.10nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517090((R)-N-(3-fluoro-4-((3- ((1-methoxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 3.30nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517081((S)-N-(3-fluoro-4-((3- ((1-methoxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 3.40nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517091((R)-1-cyclobutyl-N-(3- fluoro-4-((3-((1- methoxypr...)copy SMILES
Affinity DataIC50: 3.40nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517022((R)-3-(3,4- difluorophenyl)-N-(3- fluoro-4-((3-((1...)copy SMILES
Affinity DataIC50: 3.40nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517034((R)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 3.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517037((R)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 3.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516975(N-(4-((3-((1,3- dihydroxypropan-2- yl)amino)-1H- p...)copy SMILES
Affinity DataIC50: 3.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517047((S)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 3.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517099((S)-N-(3-fluoro-4-((3- ((1-methoxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 3.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516964(N-(3-fluoro-4-((3-((3- hydroxy-3-methylbutan-2- yl...)copy SMILES
Affinity DataIC50: 3.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517009(N-(3-fluoro-4-((3- (((2R,3R)-3- hydroxybutan-2- yl...)copy SMILES
Affinity DataIC50: 4nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517003((R)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)(me...)copy SMILES
Affinity DataIC50: 4.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517092((R)-N-(3-fluoro-4-((3- ((1-methoxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 4.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516967(N-(3-fluoro-4-((3- (((1s,3s)-3- (hydroxymethyl)cyc...)copy SMILES
Affinity DataIC50: 4.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516995((R)-N-(3-fluoro-4-((3- ((1-hydroxxypropan-2- yl)am...)copy SMILES
Affinity DataIC50: 4.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516991(N-(3-fluoro-4-((3-((1- hydroxy-2- (hydroxymethyl)b...)copy SMILES
Affinity DataIC50: 4.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517072((R)—N-(3-fluoro-4-((3-((1-hydroxypropan-2-yl)amino...)copy SMILES
Affinity DataIC50: 4.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516964(N-(3-fluoro-4-((3-((3- hydroxy-3-methylbutan-2- yl...)copy SMILES
Affinity DataIC50: 4.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517028((S)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 4.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517007(N-(3-fluoro-4-((3-((2- hydroxy-2- methylpropyl)ami...)copy SMILES
Affinity DataIC50: 4.80nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517010((R)-N-(3-fluoro-4-((3- ((3-hydroxy-3- methylbutan-...)copy SMILES
Affinity DataIC50: 4.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516998((S)-N-(3-fluoro-4-((3- ((1-hydroxybutan-2- yl)amin...)copy SMILES
Affinity DataIC50: 4.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517045((R)-1-ethyl-N-(3-fluoro- 4-((3-((1- hydroxypropan-...)copy SMILES
Affinity DataIC50: 5nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517076((R)—N-(3-fluoro-4-((3-((1-methoxypropan-2-yl)amino...)copy SMILES
Affinity DataIC50: 5.60nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516999(N-(3-fluoro-4-((3-((1- (hydroxymethyl) cyclobutyl)...)copy SMILES
Affinity DataIC50: 5.70nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517093((S)-N-(3-fluoro-4-((3- ((1-methoxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 5.90nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517006((S)-N-(3-fluoro-4-((3- ((2- hydroxypropyl)amino)- ...)copy SMILES
Affinity DataIC50: 6nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM516985((R)-N-(3-fluoro-4-((3-((1- hydroxybutan-2- yl)amin...)copy SMILES
Affinity DataIC50: 6nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517094(N-(4-((3-((4,4- difluorobutan-2- yl)amino)-1H- pyr...)copy SMILES
Affinity DataIC50: 6.20nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
LigandPNGBDBM517046((R)-N-(3-fluoro-4-((3- ((1-hydroxypropan-2- yl)ami...)copy SMILES
Affinity DataIC50: 6.40nMAssay Description:The affinity of compound binding to wild type and mutant human MET kinases is measured using Invitrogen's LanthaScreen™ Eu Kinase Binding technol...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2BZ6962US Patent
Displayed 1 to 50 (of 153 total ) | Next | Last >>
Jump to: